ES2164043T3 - Marcador detectablemente marcado, que comprende un grupo fluoroforo, una sonda fluorescente que comprende el marcador y aplicaciones de los mismos. - Google Patents

Marcador detectablemente marcado, que comprende un grupo fluoroforo, una sonda fluorescente que comprende el marcador y aplicaciones de los mismos.

Info

Publication number
ES2164043T3
ES2164043T3 ES91911322T ES91911322T ES2164043T3 ES 2164043 T3 ES2164043 T3 ES 2164043T3 ES 91911322 T ES91911322 T ES 91911322T ES 91911322 T ES91911322 T ES 91911322T ES 2164043 T3 ES2164043 T3 ES 2164043T3
Authority
ES
Spain
Prior art keywords
marker
applications
fluoroforo
detectablely
understands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91911322T
Other languages
English (en)
Inventor
Walter B Dandliker
Mao-Lin Hsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hyperion Inc
Original Assignee
Hyperion Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyperion Inc filed Critical Hyperion Inc
Application granted granted Critical
Publication of ES2164043T3 publication Critical patent/ES2164043T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036—Porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0015—Phosphorescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/045—Special non-pigmentary uses, e.g. catalyst, photosensitisers of phthalocyanine dyes or pigments
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/08—Preparation from other phthalocyanine compounds, e.g. cobaltphthalocyanineamine complex
    • C09B47/24—Obtaining compounds having —COOH or —SO3H radicals, or derivatives thereof, directly bound to the phthalocyanine radical
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/19—Rubella virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

SE SUMINISTRAN TINTES FLUORESCENTES QUE ESTAN LIBRES DE AGREGACIONES Y UNION CON EL PLASMA. ESTOS TINTES SON ADECUADOS PARA APLICACIONES TALES COMO INMUNOENSAYO DE FLUORESCENCIA, PARA LA FORMACION DE IMAGENES IN VIVO Y PARA LA TERAPIA DE TUMORES IN VIVO.
ES91911322T 1990-05-15 1991-05-15 Marcador detectablemente marcado, que comprende un grupo fluoroforo, una sonda fluorescente que comprende el marcador y aplicaciones de los mismos. Expired - Lifetime ES2164043T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52421290A 1990-05-15 1990-05-15

Publications (1)

Publication Number Publication Date
ES2164043T3 true ES2164043T3 (es) 2002-02-16

Family

ID=24088253

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91911322T Expired - Lifetime ES2164043T3 (es) 1990-05-15 1991-05-15 Marcador detectablemente marcado, que comprende un grupo fluoroforo, una sonda fluorescente que comprende el marcador y aplicaciones de los mismos.

Country Status (7)

Country Link
EP (1) EP0528991B1 (es)
JP (1) JPH05507518A (es)
AT (1) ATE206124T1 (es)
CA (1) CA2082934C (es)
DE (1) DE69132744T2 (es)
ES (1) ES2164043T3 (es)
WO (1) WO1991018007A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5880287A (en) * 1990-05-15 1999-03-09 Hyperion, Inc. Polyoxyhydrocarbyl related products and methods for fluorescence assays
US5919922A (en) * 1990-05-15 1999-07-06 Hyperion, Inc. Fluorescent dyes free of aggregation and serum binding
US6060598A (en) * 1990-05-15 2000-05-09 Hyperion, Inc. Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding
TW235298B (es) * 1992-02-27 1994-12-01 Ciba Geigy
EP0632893A4 (en) * 1992-03-23 1997-01-02 Diatron Corp FLUORESCENCE IMMUNOASSAYS USING FLUORESCENT MATRICES FREE OF AGGREGATE AND SERUM BINDER.
US5599924A (en) * 1992-08-14 1997-02-04 Trustees Of The University Of Pennsylvania Electron-deficient porphyrins and processes and intermediates for preparing same
US5817830A (en) * 1992-08-14 1998-10-06 Trustees Of The University Of Pennsylvania Pyrrolic compounds
US5371199B1 (en) * 1992-08-14 1995-12-26 Univ Pennsylvania Substituted porphyrins porphyrin-containing polymers and synthetic methods therefor
US5493017A (en) * 1992-08-14 1996-02-20 The Trustees Of The University Of Pennsylvania Ring-metalated porphyrins
US5824799A (en) * 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US7083984B2 (en) 1993-09-24 2006-08-01 Biosite, Inc. Hybrid phthalocyanine derivatives and their uses
US7322927B2 (en) 1993-09-24 2008-01-29 Biosite, Inc. Hybrid phthalocyanine derivatives and their uses
US6238931B1 (en) 1993-09-24 2001-05-29 Biosite Diagnostics, Inc. Fluorescence energy transfer in particles
KR100397020B1 (ko) * 1995-01-30 2004-04-29 다이이치 가가쿠 야쿠힝 가부시키가이샤 진단용마커
WO1996029367A1 (en) * 1995-03-23 1996-09-26 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US5679661A (en) * 1995-07-25 1997-10-21 The Procter & Gamble Company Low hue photodisinfectants
US5916481A (en) * 1995-07-25 1999-06-29 The Procter & Gamble Company Low hue photobleaches
US6083486A (en) * 1998-05-14 2000-07-04 The General Hospital Corporation Intramolecularly-quenched near infrared fluorescent probes
EP1082138B1 (en) * 1998-06-05 2004-08-25 The Board Of Regents, The University Of Texas System Texaphyrin conjugates and uses thereof
DE69922216T2 (de) 1998-08-28 2005-12-01 Destiny Pharma Ltd. Porphyrin derivate, ihre verwendung in der photodynamischen therapie und diese enthaltende medizinische geräte
AU3094899A (en) * 1999-03-05 2000-09-21 Case Western Reserve University A composition comprising a photo-oxidising agent and uses of the agent
US7005518B2 (en) 2002-10-25 2006-02-28 Li-Cor, Inc. Phthalocyanine dyes
US8835000B2 (en) * 2011-12-23 2014-09-16 General Electric Company High-density fluorescent dye clusters
JP7280577B2 (ja) * 2019-04-22 2023-05-24 東洋インキＳｃホールディングス株式会社 蛍光バイオイメージング方法
BR112022020521A2 (pt) * 2020-04-10 2023-03-07 Rakuten Medical Inc Compostos de corante ftalocianina, conjugados e métodos de uso dos mesmos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU603999B2 (en) * 1985-10-23 1990-12-06 Photochemical Co., Ltd. Porphyrin derivatives, and their production and use
JPS62249986A (ja) * 1986-04-21 1987-10-30 Hamari Yakuhin Kogyo Kk ポルフイリン誘導体
JPH07100714B2 (ja) * 1987-03-03 1995-11-01 株式会社三和化学研究所 ランプテロフラビン及びその製法
JPH0690208B2 (ja) * 1987-04-01 1994-11-14 株式会社日立製作所 自動分析装置
DE3809671A1 (de) * 1988-03-18 1989-09-28 Schering Ag Porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel

Also Published As

Publication number Publication date
EP0528991A4 (en) 1995-09-06
CA2082934C (en) 2003-08-05
EP0528991A1 (en) 1993-03-03
EP0528991B1 (en) 2001-09-26
CA2082934A1 (en) 1991-11-16
DE69132744D1 (de) 2001-10-31
DE69132744T2 (de) 2002-10-10
ATE206124T1 (de) 2001-10-15
WO1991018007A1 (en) 1991-11-28
JPH05507518A (ja) 1993-10-28

Similar Documents

Publication Publication Date Title
ES2164043T3 (es) Marcador detectablemente marcado, que comprende un grupo fluoroforo, una sonda fluorescente que comprende el marcador y aplicaciones de los mismos.
ES2163393T3 (es) Porfirina fluorescente y ftalocianina fluorescente - derivados de polietilenglicol, poliol y sacaridos como sondas fluorescentes.
ES2118992T3 (es) Derivados ciclicos, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2062383T3 (es) Nuevo colorante fluorescente.
BR9907313A (pt) Composição para a tintura de oxidação das fibras queratìnicas, processo de tintura de oxidação das fibras queratìnicas e dispositivos com vários compartimentos
ES2151277T3 (es) Composiciones que comprenden conjugados de acido cis-docosahexaenoico y taxotere.
ES2103298T3 (es) Tintes para el cabello.
ES2137152T3 (es) Composicion a base de polimero de estireno.
ES2058164T3 (es) Conjugados fluorescentes y ensayo de diagnostico biologico.
ES2067758T3 (es) Benzofenoleteres-esteres, procedimiento para su obtencion, asi como su empleo para mejorar la estabilidad a la luz de los teñidos de poliester.
ES2058843T3 (es) Utilizacion de composiciones degradables por via enzimatica para el revestimiento de aditivos alimentarios destinados a los rumiantes.
BRPI0414980A (pt) péletes contendo corante, para tingimento de fibras de queratina
ES2104881T3 (es) Procedimiento para teñir papel con colorantes diazoicos.
ES2116324T3 (es) Antagonistas de leucotrieno sustituidos con fenilfenol.
ES2117474T3 (es) Derivados n-sustituidos del 4-hidroxiindol y composiciones de tinte de fibras queratinicas que los contienen.
ES2062294T5 (es) Uso de un aditivo como detergente, dispersante y antioxidante para combustibles y aceites lubricantes.
ES2155664T3 (es) Colorantes reactivos, obtencion y uso de los mismos.
ES2095900T3 (es) Mezcla de colorantes dispersantes y procedimiento de coloracion.
ES8502147A1 (es) Procedimiento para la produccion de compuestos poliazoicos
JPS524200A (en) Fluorescence eye catcher sigh-board by stimulation of ultra-violet ray s
ATE524523T1 (de) Aox-freie marineblaue und schwarze dispersionsfarbstoffe
NL194058B (nl) Gemengd, groen licht emitterend luminescerend materiaal en kathodestraalbuis waarin dit luminescerende materiaal wordt gebruikt.
ES2156332T3 (es) Colorantes disazoicos para el teñido de materiales que contienen celulosa.
ES8106324A1 (es) Procedimiento para preparar colorantes monoazoicos dispersos
ES384678A1 (es) Un procedimiento para la preparacion de colorantes azoicos cationicos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 528991

Country of ref document: ES